ACT-293987 in Pulmonary Arterial Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

709

Participants

Timeline

Start Date

July 7, 2010

Primary Completion Date

August 26, 2021

Study Completion Date

August 26, 2021

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

ACT-293987

Tablets, twice daily

Trial Locations (157)

Unknown

Mobile

Phoenix

Tucson

La Jolla

Los Angeles

Sacramento

Torrance

Newark

Atlanta

Augusta

Austell

Carmel

Iowa City

Kansas City

Louisville

New Orleans

Baltimore

Boston

Ann Arbor

Detroit

Troy

Rochester

Chesterfield

St Louis

Newark

Islandia

New York

The Bronx

Durham

Winston-Salem

Cincinnati

Cleveland

Columbus

Bend

Portland

Doylestown

Philadelphia

York

Nashville

Dallas

Houston

Norfolk

Richmond

Madison

Milwaukee

Buenos Aires

Corrientes

Córdoba

Adelaide

Bedford Park

Chermside

Concord

Darlinghurst

Fitzroy

Hobart

Murdoch

New Lambton

Parkville

Graz

Vienna

Minsk

Brussels

Leuven

Edmonton

Vancouver

Winnipeg

Ottawa

Toronto

Montreal

Québec

Saskatoon

Santiago

Beijing

Guangzhou

Shanghai

Bogotá

Prague

Aarhus

Copenhagen

Bron

Le Kremlin-Bicêtre

Lille

Toulouse

Berlin

Cologne

Dresden

Giessen

Greifswald

Hanover

Heidelberg

Leipzig

Löwenstein

Regensburg

Alexandroupoli

Athens

Thessaloniki

Budapest

Debrecen

Pécs

Szeged

Ahmedabad

Chennai

Hyderabad

Dublin

Haifa

Jerusalem

Petah Tikva

Rehovot

Tel Aviv

Tel Litwinsky

Kuala Lumpur

Mexico City

Amsterdam

Maastricht

Rotterdam

Lima

Gdansk

Krakow

Lodz

Otwock

Bucharest

Iași

Barnaul

Kemerovo

Moscow

Novosibirsk

Saint Petersburg

Tomsk

Yekaterinburg

Belgrade

Singapore

Bratislava

Košice

Incheon

Seoul

Barcelona

Madrid

Gothenburg

Linköping

Umeå

Uppsala

Basel

Bern

Geneva

Lausanne

Kaohsiung City

Taipei

Khon Kaen

Adana

Istanbul

Izmir

Dnipro

Kharkiv

Kyiv

Lviv

Glasgow

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY